在美国提供高质量计划生育服务:美国人口事务办公室建议(2024年修订版)
美国卫生与公众服务部人口事务办公室对2014年CDC与OPA发布的《提供高质量计划生育服务建议》进行2024年修订,提出为育龄人群提供以人为中心、以健康公平为视角的性与生殖健康服务建议,涵盖避孕、妊娠检测与咨询、早期妊娠管理、性传播感染与HIV预防检测及家庭建设等服务。
要点
- 建议为育龄人群提供高质量性与生殖健康服务,内容相关时也可指导任何年龄人群的照护。
- 服务涵盖家庭建设、避孕、妊娠检测与咨询、早期妊娠管理、性传播感染与HIV预防检测及其他预防服务。
- 建议采用健康公平视角,认识结构性及人际种族主义、阶级主义、能力主义及基于性取向和性别认同的偏见对健康的影响。
核心结论
- 本次更新旨在就提供以人为中心、关注个人需求、价值观和偏好的性与生殖健康照护给出指导,并提供具体建议及连接相关指南、原始研究和其他资源以支持最佳实践。
研究设计与样本
- 由美国卫生与公众服务部助理卫生部长办公室下属人口事务办公室制定,是对2014年CDC与OPA发布的《提供高质量计划生育服务建议》的更新。
主要发现
- 过去十年美国性与生殖健康照护提供发生了技术进展、对长期存在的不公平的认识以及其他法律和监管变化等改变,更新建议的设计考虑了这一更广泛背景。
关键数值与推荐
- 建议为育龄人群提供高质量性与生殖健康服务,内容相关时也可用于指导任何年龄人群的照护,包括家庭建设服务、避孕、妊娠检测与咨询、早期妊娠管理、性传播感染与HIV预防和检测服务及其他预防保健服务。
- 建议使卫生保健提供者具备知识、技能和态度,确保所有人不论性别、性取向和性别认同、年龄、残疾或种族等个人特征,其性与生殖健康需求都能得到满足。
- 建议采用健康公平视角,认识结构性及人际种族主义、阶级主义、能力主义以及基于性取向和/或性别认同的偏见对健康和提供高质量性与生殖健康照护的影响。
临床怎么用
- 主要受众为向育龄人群提供性与生殖健康服务的提供者和潜在提供者,包括在专门提供性与生殖健康服务的临床环境中工作的提供者(含Title X计划生育项目资助者)以及可能识别性与生殖健康需求并转诊的初级保健提供者和其他专科提供者。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This update, titled Providing Quality Family Planning Servicesa in the United States: Recommendations of the U.S. Office of Population Affairs (Revised 2024), provides recommendations developed by the Office of Population Affairs (OPA) within the Office of the Assistant Secretary for Health at the U.S. Department of Health and Human Services (HHS). These recommendations represent an update to Providing Quality Family Planning (QFP) Services: Recommendations of the Centers for Disease Control and Prevention (CDC) and the U.S. Office of Population Affairs (OPA), originally published in 2014. The updated recommendations outline how to provide quality sexual and reproductive health (SRH) services for people of reproductive age but can also be used to guide the care of people of any age when the content is relevant to their needs, including family-building services, contraception, pregnancy testing and counseling, early pregnancy management, sexually transmitted infections (STIs) and human immunodeficiency virus (HIV) prevention and testing services, and other preventive health services. The recommendations aim to enable health care providers with the knowledge, skills, and attitudes to ensure that all people, regardless of individual characteristics such as sex, sexual orientation and gender identity, age, disability, or race, can have their SRH needs met. The primary audience for these recommendations is providers and potential providers of SRH services to people of reproductive age, such as providers working in clinical settings dedicated to SRH service delivery, including those funded by the Title X family planning programb as well as primary care providers and other subspecialty providers who may identify SRH needs and make referrals. During the past decade, several changes have taken place in the United States that have affected SRH care delivery, including technological advances, recognition of long-standing inequities, and other legal and regulatory changes. This broader context has been considered in designing the updated recommendations. This update of the QFP aims to provide guidance on the provision of person-centered SRH care focused on individuals' needs, values, and preferences. The update offers specific recommendations for how to provide high-quality SRH care and connects users to relevant guidelines, primary research, and other resources to inform best practices. In addition to incorporating new evidence, this update incorporates newer approaches to care, including adopting a health equity lens that recognizes the impact of structural and interpersonal racism, classism, ableism, and bias based on sexual orientation and/or gender identity on health and the provision of quality SRH care. OPA will update these QFP recommendations periodically to reflect new findings in the scientific literature and revisions to the clinical guidelines referenced in this update.
引用
- Romer SE, Blum J, Borrero S, et al. Providing Quality Family Planning Services in the United States: Recommendations of the U.S. Office of Population Affairs (Revised 2024). Am J Prev Med. 2024. PMID: 39570204. doi:10.1016/j.amepre.2024.09.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。